Fortress Biotech Repays Remaining $15 Million Debt Under Oaktree Credit Agreement

Filing content

Fortress Biotech announced the full repayment of the remaining $15 million principal under its Oaktree credit agreement, resulting in the termination of the agreement and the release of all related security interests.